Christine Herdman

NPI: 1487783767
Total Payments
$7,911
2024 Payments
$1,688
Companies
35
Transactions
516
Medicare Patients
2,661
Medicare Billing
$471,971

Payment Breakdown by Category

Food & Beverage$7,881 (99.6%)
Education$30.81 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,881 514 99.6%
Education $30.81 2 0.4%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,960 170 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $858.54 49 $0 (2024)
Janssen Biotech, Inc. $857.73 90 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $631.85 40 $0 (2024)
Valeant Pharmaceuticals North America LLC $274.92 16 $0 (2017)
IRONWOOD PHARMACEUTICALS, INC $231.81 15 $0 (2024)
Regeneron Healthcare Solutions, Inc. $195.06 10 $0 (2024)
Synergy Pharmaceuticals Inc $187.92 19 $0 (2018)
PFIZER INC. $175.21 13 $0 (2024)
Ardelyx, Inc. $172.40 9 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,688 91 ABBVIE INC. ($649.53)
2023 $1,240 68 ABBVIE INC. ($594.06)
2022 $785.41 45 ABBVIE INC. ($616.59)
2021 $539.90 33 AbbVie Inc. ($403.65)
2020 $271.38 16 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($67.02)
2019 $874.55 57 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($214.46)
2018 $1,356 105 AbbVie, Inc. ($316.60)
2017 $1,157 101 Valeant Pharmaceuticals North America LLC ($274.92)

All Payment Transactions

516 individual payment records from CMS Open Payments — Page 1 of 21

Date Company Product Nature Form Amount Type
12/20/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $20.12 General
Category: GASTROENTEROLOGY
12/16/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $22.54 General
Category: Immunology
12/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $25.44 General
Category: Gastroenterology
12/06/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $14.11 General
Category: GI
12/05/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $28.47 General
Category: INFLAMMATION AND IMMUNOLOGY
12/03/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $16.50 General
Category: Immunology
12/02/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.26 General
Category: IMMUNOLOGY
11/27/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $17.86 General
Category: IMMUNOLOGY
11/22/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $15.08 General
Category: ENDOCRINOLOGY
11/21/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $17.61 General
Category: GASTROENTEROLOGY
11/20/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $12.00 General
Category: Immunology
11/07/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $19.62 General
Category: IMMUNOLOGY
11/06/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $20.75 General
Category: GASTROENTEROLOGY
11/06/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $20.64 General
Category: IMMUNOLOGY
11/04/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $14.59 General
Category: IMMUNOLOGY
10/31/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN, PLENVU Food and Beverage In-kind items and services $22.19 General
Category: Gastroenterology
10/29/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $17.74 General
Category: GI
10/16/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.52 General
Category: IMMUNOLOGY
10/10/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $24.02 General
Category: Immunology
10/10/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $23.17 General
Category: VIROLOGY
10/08/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $19.31 General
Category: IMMUNOLOGY
10/07/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $26.02 General
Category: Rare Disease
09/25/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.89 General
Category: IMMUNOLOGY
09/24/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $18.91 General
Category: Immunology
09/13/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $12.24 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 734 7,670 $619,190 $198,023
2022 16 622 4,551 $426,901 $131,830
2021 16 690 740 $352,657 $77,537
2020 13 615 655 $304,932 $64,581
Total Patients
2,661
Total Services
13,616
Medicare Billing
$471,971
Procedure Codes
61

All Medicare Procedures & Services

61 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J3380 Injection, vedolizumab, 1 mg Office 2023 16 6,900 $254,460 $119,413 46.9%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 132 132 $131,983 $26,899 20.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 92 120 $25,461 $10,981 43.1%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 107 108 $63,959 $8,299 13.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 87 102 $14,757 $5,937 40.2%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 32 32 $23,263 $5,679 24.4%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 71 71 $24,822 $4,544 18.3%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 30 30 $13,907 $3,121 22.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 32 32 $26,301 $2,982 11.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 26 26 $7,476 $2,878 38.5%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 14 14 $9,267 $2,030 21.9%
91010 Study of esophagus to assess movement Facility 2023 27 27 $7,863 $1,362 17.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 18 19 $4,349 $1,207 27.8%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 16 23 $2,356 $1,173 49.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 14 14 $3,203 $916.10 28.6%
43450 Dilation of esophagus Facility 2023 20 20 $5,763 $600.90 10.4%
J3380 Injection, vedolizumab, 1 mg Office 2022 11 3,900 $130,299 $67,847 52.1%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 100 100 $100,491 $19,487 19.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 96 123 $15,392 $7,961 51.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 88 90 $55,564 $6,774 12.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 62 71 $13,365 $6,730 50.4%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 67 67 $20,159 $5,147 25.5%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 42 42 $37,798 $4,199 11.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 28 28 $8,051 $3,369 41.8%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 16 16 $12,073 $2,965 24.6%

About Christine Herdman

Christine Herdman is a Gastroenterology healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487783767.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christine Herdman has received a total of $7,911 in payments from pharmaceutical and medical device companies, with $1,688 received in 2024. These payments were reported across 516 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,881).

As a Medicare-enrolled provider, Herdman has provided services to 2,661 Medicare beneficiaries, totaling 13,616 services with total Medicare billing of $471,971. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Newark, DE
  • Active Since 03/05/2007
  • Last Updated 07/26/2011
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1487783767

Products in Payments

  • XIFAXAN (Drug) $739.24
  • MAVYRET (Drug) $694.31
  • STELARA (Biological) $533.68
  • SKYRIZI (Biological) $487.80
  • RINVOQ (Biological) $454.49
  • HUMIRA (Biological) $316.71
  • DUPIXENT (Biological) $312.68
  • Amitiza (Drug) $303.00
  • Humira (Biological) $252.40
  • Entyvio (Biological) $222.26
  • XIFAXANIBSD (Drug) $215.93
  • VIBERZI (Drug) $200.69
  • Trulance (Drug) $187.92
  • IBSRELA (Drug) $172.40
  • TREMFYA (Drug) $168.49
  • LINZESS (Drug) $165.74
  • Linzess (Drug) $161.29
  • XELJANZ (Drug) $151.23
  • CREON (Drug) $145.70
  • REMICADE (Biological) $140.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Newark